Incidence of malignant pericardial effusion in pericardiocentesis patients and post-procedure care: an oncology center pilot study.

Autor:	Jamil G; Department of Cardiology, Tawam Hospital Al Ain, United Arab Emirates., Jamil S; Department of Internal Medicine, Tawam Hospital Al Ain, United Arab Emirates., Saleem A; Department of Infectious Disease, Tawam Hospital Al Ain, United Arab Emirates., AlKindi F; Department of Cardiology, Tawam Hospital Al Ain, United Arab Emirates., Aziz F; Medical University of Graz Graz, Austria., Al Zaabi A; Department of Internal Medicine, Tawam Hospital Al Ain, United Arab Emirates., Sharma C; Department of Internal Medicine, United Arab Emirates University Al Ain, United Arab Emirates., Mesameh H; Department of Nursing, Tawam Hospital Al Ain, United Arab Emirates., Yasin J; Department of Internal Medicine, United Arab Emirates University Al Ain, United Arab Emirates., Khan C; Division of Hematology Oncology, Allegheny General Hospital Pittsburgh, Pennsylvania, United States., AlKaabi J; Department of Internal Medicine, United Arab Emirates University Al Ain, United Arab Emirates.
Jazyk:	angličtina
Zdroj:	American journal of translational research [Am J Transl Res] 2023 May 15; Vol. 15 (5), pp. 3355-3364. Date of Electronic Publication: 2023 May 15 (Print Publication: 2023).
Abstrakt:	The etiology of pericardial effusion can affect many important factors during and after pericardiocentesis. The frequency of etiologies varies among different patient populations. Pericardiocentesis is an important diagnostic and therapeutic intervention; however, data on the characteristics of malignant pericardial effusion are lacking in the United Arab Emirates (UAE). Thus, we conducted a pilot study on the incidence and post-procedure care of patients who underwent pericardiocentesis in our facility to enhance their management and treatment. This retrospective study included all cases of pericardiocentesis between 2011-2019. Epidemiological, clinical, and biochemical data were collected and analyzed. Pericardial fluid analysis, malignancy type, recurrence rate, need for a repeat procedure, and echocardiography findings were reviewed. Thirty-three patients (mean: 47.2 years) underwent pericardiocentesis, and 22 of these patients (66.7%) had malignancy. The predominant cancers were breast cancer (27.3%), lung cancer (27.3%), exudative pericardial effusion and malignant effusion (68%), and bloody fluid (73%). An average of 350 ml was drained from the patients, and the drain was retained for 4 days. Six patients (18.2%) had re-accumulation of pericardial effusion, and 4 patients required repeat procedures. All patients underwent post-procedure echocardiography, and 82% underwent follow-up echo within one week. More than two-thirds of our cancer patients had malignant pericardial effusion. The early diagnosis of the etiology of pericardial effusion may alter its management and prognosis. We would like to conduct further research to determine its influence on the prognosis of cancer patients in the UAE. Competing Interests: None. (AJTR Copyright © 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu